Company Overview and News

136
Revisiting the Trump Portfolios - The Big Picture

15h ritholtz
Betting Against Trump Was a Market-Beater The companies the president disparaged have done much better than those he favored. Bloomberg, January 10, 2018
STZ.B XOM TWX GLSSP TWTR JBK TMUSP TMUS TFG TYT STZ UTX TWC 7203 9984 BA LMT FB TM PYPL SFTBF GS BOE GM SFTBY CLNS GSC NYTAB TOYOF GSJ S RXN PEP CLNY TSLA GJS

1
Tokyo stocks turn lower in thin trading

16h japantimes.co.jp
Stocks fell back on the Tokyo Stock Exchange on Monday, as investors retreated to the sidelines amid a dearth of fresh trading incentives.
ITOCY JAPAF 2914 SFTBF JFEEF TOELY KDDIY SUOPY JAPAY ITOCF 5411 9984 SUMCF KDDIF 8035 TOELF SFTBY

37
T-Mobile runs behind-the-scenes PR push to support Sprint deal

17h reuters
(Reuters) - T-Mobile US Inc (TMUS.O) is asking smaller wireless operators that piggyback off its network to issue public statements or even write newspaper editorials to help persuade antitrust regulators to approve its proposed $26 billion acquisition of Sprint Corp (S.N).
S TMUSP TMUS 9984 SFTBF DTEGF DTEGY SFTBY

37
T-Mobile runs behind-the-scenes PR push to support Sprint deal

17h channelnewsasia
T-Mobile US Inc is asking smaller wireless operators that piggyback off its network to issue public statements or even write newspaper editorials to help persuade antitrust regulators to approve its proposed US$26 billion acquisition of Sprint Corp .
S TMUSP TMUS 9984 SFTBF DTEGF DTEGY SFTBY

1
Saudi PIF in talks to invest in aspiring Tesla rival Lucid: sources

19h japantimes.co.jp
PIF, the Saudi Arabian sovereign wealth fund that Tesla Inc. CEO Elon Musk has said could help him fund a $72 billion deal to take his electric carmaker private, is in talks to invest in aspiring Tesla rival Lucid Motors Inc., sources said Sunday.
OCLCF 9984 SFTBF SFTBY ORCL

1
Saudi PIF in talks to invest in aspiring Tesla rival Lucid: Sources

23h channelnewsasia
PIF, the Saudi Arabian sovereign wealth fund that Tesla Inc CEO Elon Musk has said could help him fund a US$72 billion deal to take his electric car maker private, is in talks to invest in aspiring Tesla rival Lucid Motors Inc, people familiar with the matter said on Sunday.
OCLCF 9984 SFTBF SFTBY ORCL

1
Exclusive: Saudi PIF in talks to invest in aspiring Tesla rival Lucid - sources

2018-08-19 reuters
(Reuters) - PIF, the Saudi Arabian sovereign wealth fund that Tesla Inc (TSLA.O) CEO Elon Musk has said could help him fund an offer to take his electric car maker private, is in talks to invest in aspiring Tesla rival Lucid Motors Inc, people familiar with the matter said on Sunday.
OCLCF 9984 SFTBF SFTBY ORCL

1
Exclusive: Saudi PIF in talks to invest in aspiring Tesla rival Lucid - sources

2018-08-19 channelnewsasia
PIF, the Saudi Arabian sovereign wealth fund that Tesla Inc CEO Elon Musk has said could help him fund an offer to take his electric car maker private, is in talks to invest in aspiring Tesla rival Lucid Motors Inc, people familiar with the matter said on Sunday.
OCLCF 9984 SFTBF SFTBY ORCL

3
Indonesia's Go-Jek close to profits in all segments, except transport: CEO

2018-08-17 theedgemarkets
JAKARTA (Aug 17): Go-Jek, Indonesia’s first billion-dollar startup, is “extremely close” to achieving profitability in all its segments, except transportation, its founder and CEO Nadiem Makarim told Reuters.
GOOGL GOOG 9984 SFTBF SFTBY

3
Indonesia's Go-Jek close to profits in all segments, except transport: CEO - Channel NewsAsia

2018-08-17 channelnewsasia
JAKARTA: Go-Jek, Indonesia's first billion-dollar startup, is "extremely close" to achieving profitability in all its segments, except transportation, its founder and CEO Nadiem Makarim told Reuters.
GOOGL GOOG 9984 SFTBF SFTBY

0
DoorDash More Than Doubles Valuation to $4 Billion - WSJ

2018-08-17 wsj
DoorDash Inc. on Thursday said it raised $250 million in a round of funding that values the prepared food-delivery startup at $4 billion, more than doubling its valuation for the second time in five months.
9984 SFTBF SFTBY

0
Policybazaar appoints Ashish Gupta as CEO of health tech venture DocPrime

2018-08-16 moneycontrol
Insurance portal Policybazaar today said it has appointed Ashish Gupta as the Chief Executive Officer of its new healthtech venture, DocPrime. Besides, it has named Richit Ummat as the Chief Operating Officer of the new venture.
9984 SFTBF SFTBY

0
SoftBank and Thai telecom firm to launch cheap, fast internet exchange service

2018-08-16 japantimes.co.jp
BANGKOK – SoftBank Group Corp. and True Corporation Public Co. Ltd., Thailand’s telecommunications conglomerate, have teamed up to launch an internet exchange service with the aim of capitalizing on growing digital data traffic in the country.
9984 SFTBF SFTBY

0
Paytm Mall eyes $10 billion in gross sales by March 2019

2018-08-16 livemint
New Delhi: Alibaba Group-backed Paytm Mall is aiming for a nearly threefold rise in annualized gross sales to $10 billion by March 2019 as it ramps up efforts to garner a bigger slice of India’s expanding online retail market.
9984 SFTBF SFTBY

1
Apple accused of pressuring game rivals in Japan - Nikkei

2018-08-16 reuters
TOKYO, Aug 16 (Reuters) - Japanese regulators are investigating Apple Inc over allegations it unfairly pressured Yahoo Japan Corp to slow the expansion of its online games platform, which competes with Apple’s App Store, Japanese media reported on Thursday.
4689 AAPL SQNNY YAHOY 9984 SFTBF SFTBY YAHOF

Related Articles

REPH: Recro Pharma Analysis and Research Report

23h - Asif

Overview Recro Pharma is a specialty pharmaceutical company that operates through two business divisions: an Acute Care division and a revenue-generating CDMO division. Each of these divisions are deemed to be reportable segments for financial reporting purposes. The company's Acute Care segment is primarily focused on developing and commercializing innovative products for hospital and related acute care settings. The company's lead product candidate is a proprietary injectable form of meloxicam, a long-acting preferential COX-2 inhibitor. IV meloxicam has successfully completed three Phase III clinical trials for the management of moderate to severe pain, consisting of two pivotal efficacy trials and a large double-blind Phase III safety trial, as well as other safety studies. Overall, the total new drug application, or NDA, program included over 1,400 patients. In late July 2017, the company submitted a NDA to the U.S. Food and Drug Administration, or FDA, for IV meloxicam...

ACHN: Achillion Pharmaceuticals Analysis and Research Report

23h - Asif

Overview Achillion Pharmaceuticals is a clinical-stage biopharmaceutical company focused on advancing its oral factor D inhibitors into late-stage development and commercialization. Each of the drug candidates in its oral factor D portfolio was discovered in its laboratories and is wholly owned by it. Achillion Pharmaceuticals is focusing its drug development activities on alternative pathway-mediated, rare diseases where there are no approved therapies or where existing therapies are inadequate for patients. To advance its investigational drugs into phase III and commercialization, the company plan to work closely with key stakeholders including patients, payors, regulators and healthcare professionals. The company's first-generation factor D inhibitor, ACH-4471, has demonstrated preliminary clinical proof-of-concept in patients with C3 glomerulopathy, or C3G, a disease affecting the kidney, and paroxysmal nocturnal hemoglobinuria, or PNH, a blood disorder, and has advanced...

BTE: Baytex Energy Trust Analysis and Research Report

2018-08-20 - Asif

General Baytex Energy Corp. was incorporated on October 22, 2010 pursuant to the provisions of the ABCA. Baytex is the successor to the business of Baytex Energy Trust, which was transitioned to Baytex on December 31, 2010. Inter-Corporate Relationships The following table provides the name, the percentage of voting securities owned by it and the jurisdiction of incorporation, continuance, formation or organization of its material subsidiaries either, direct and indirect, as at the date hereof. ||Percentage of voting securities (directly or indirectly)|Jurisdiction of Incorporation/Formation| | ------------ | ------------: | :------------: | |Baytex Energy Ltd.|100%|Alberta| |Baytex Energy USA, Inc.|100%|Delaware| |Baytex Energy Partnership|100%|Alberta| Organizational Structure The following simplified diagram shows the inter-corporate relationships among it and its material subsidiaries as of the date hereof. <img src="https://www.sec.gov/A...